Analyst Research: Agios Pharmaceuticals Inc (AGIO.O)

AGIO.O on Nasdaq

96.60USD
27 Mar 2015
Change (% chg)

$4.93 (+5.38%)
Prev Close
$91.67
Open
$91.79
Day's High
$98.15
Day's Low
$91.79
Volume
567,575
Avg. Vol
685,041
52-wk High
$138.85
52-wk Low
$31.42

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
Thomson Reuters Stock Report - AGIOS PHARMACEUTICALS INC (AGIO-O) 27 Mar 2015 Thomson Reuters Stock Report 11 25.00
Value Graph: AGIOS PHARMA -- AGIO 26 Mar 2015 Ford Investor Services, Inc. 1 12.00
ValuEngine Industry Report for Medical Products(AGIO) 23 Mar 2015 ValuEngine, Inc. 10 49.00
ValuEngine Rating and Forecast Report for AGIO 22 Mar 2015 ValuEngine, Inc. 11 25.00
Agios Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 20 Mar 2015 Reuters Investment Profile 12 20.00
TheStreet.com Ratings Stock Report For: AGIOS PHARMACEUTICALS (AGIO) 14 Mar 2015 TheStreet.com Ratings 5 10.00
TheStreet.com Ratings Stock Report For: AGIOS PHARMACEUTICALS (AGIO) 7 Mar 2015 TheStreet.com Ratings 5 10.00
AGIO.OQ - Event Transcript of Agios Pharmaceuticals Inc conference call, Mar. 02, 2015 / 4:50PM ET 2 Mar 2015 Thomson Reuters StreetEvents 7 75.00
AGIO.OQ - Event Transcript of Agios Pharmaceuticals Inc conference call, Nov. 07, 2014 / 8:00AM ET 7 Nov 2014 Thomson Reuters StreetEvents 10 75.00
 
Name Age Since Current Position

David Schenkein

56 2013 Chief Executive Officer, Director

Duncan Higgons

59 Chief Operating Officer

Shin-San Michael Su

2012 Senior Vice President - research & development

Scott Biller

58 Chief Scientific Officer

Chris Bowden

2014 Chief Medical Officer
Search Stocks